New York, NY -- (SBWIRE) -- 01/26/2018 -- WiseGuyReports.com adds "Global TB Diagnostic Market 2015-2019" reports to its Database.

About TB Diagnostics 
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world's deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio's analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

Covered in this Report 
The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio's report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

Key Geographies 
- Americas 
- APAC 
- EMEA

Key Vendors 
- Abbott 
- Alere 
- Becton, Dickinson 
- F. Hoffmann-La Roche

Other Prominent Vendors 
- Siemens 
- BioMérieux 
- Cepheid 
- Hain Lifescience 
- Hologic 
- Ortho Clinical 
- Epistem UK 
- Eiken Chemical Japan 
- Alere US

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/98746-global-tb-diagnostic-market-2015-2019                              

  

Market Driver 
- High Prevalence of TB 
- For a full, detailed list, view our report

Market Challenge 
- Insensitivity of Spear Microscopy 
- For a full, detailed list, view our report

Market Trend 
- Intensification of Rapid Tests in Developing Countries 
- For a full, detailed list, view our report

Key Questions Answered in this Report 
- What will the market size be in 2019 and what will the growth rate be? 
- What are the key market trends? 
- What is driving this market? 
- What are the challenges to market growth? 
- Who are the key vendors in this market space? 
- What are the market opportunities and threats faced by the key vendors? 
- What are the strengths and weaknesses of the key vendors?                                                                                                                                                    

Table Of Contents

Executive Summary 
02. List of Abbreviations 
03. Scope of the Report 
03.1 Product Offerings 
04. Market Research Methodology 
04.1 Market Research Process 
    04.2 Research Methodology 
05. Introduction 
06. Market Landscape 
    06.1 Market Overview 
    06.2 Market Size and Forecast 
    06.3 Five Forces Analysis 
07. Prevalence and Incidence Rate 
08. Advances in Technology 
    08.1 Second-generation Nucleic Acid Detection 
    08.2 Next-generation Nucleic Acid Detection 
09. TB Diagnostics Pipeline 
10. Market Segmentation by Disease Stage 
    10.1 Global Latent TB Diagnostics Market 
    10.2 Global Active TB Diagnostics Market 
    10.3 Global Drug Susceptibility Tests Market 
11. Geographical Segmentation 
    11.1 Global TB Diagnostics Market in APAC 
      11.1.1 India 
    11.2 Global TB Diagnostics Market in Americas 
      11.2.1 Brazil 
    11.3 Global TB Diagnostics Market in EMEA 
      11.3.1 South Africa 
12. Buying Criteria 
13. Market Growth Drivers 
14. Drivers and Their Impact 
15. Market Challenges 
16. Impact of Drivers and Challenges 
17. Market Trends 
18. Trends and Their Impact 
19. Vendor Landscape 
    19.1 Competitive Scenario 
      19.1.1 Key News 
      19.1.2 Mergers and Acquisitions 
    19.2 Market Share Analysis 2013 
      19.2.1 Abbott Diagnostics 
      19.2.2 Alere 
      19.2.3 BD 
      19.2.4 Roche Diagnostics 
    19.3 Other Prominent Vendors 
20. Key Vendor Analysis 
    20.1 Abbott Diagnostics 
      20.1.1 Key Facts 
      20.1.2 Business Overview 
      20.1.3 Geographical Presence 
      20.1.4 SWOT Analysis 
    20.2 Alere 
      20.2.1 Key Facts 
      20.2.2 Business Overview 
      20.2.3 Business Segmentation by Revenue 2013 
      20.2.4 Business Segmentation by Revenue 2012 and 2013 
      20.2.5 Geographical Segmentation by Revenue 2013 
      20.2.6 Business Strategy 
      20.2.7 Recent Developments 
      20.2.8 SWOT Analysis 
    20.3 BD 
      20.3.1 Key Facts 
      20.3.2 Business Description 
      20.3.3 Business Segmentation 
      20.3.4 Revenue Segmentation by Business 
      20.3.5 Segmental Revenue Comparison 2013 and 2012 
      20.3.6 Revenue Segmentation by Geography 
      20.3.7 Business Strategy 
      20.3.8 Key Developments 
      20.3.9 SWOT Analysis 
    20.4 Roche Diagnostics 
      20.4.1 Key Facts 
      20.4.2 Business Overview 
      20.4.3 Business Segmentation by Revenue 2014 
      20.4.4 Business Segmentation by Revenue 2013 and 2014 
      20.4.5 Geographical Segmentation by Revenue 2014 
      20.4.6 Business Strategy 
      20.4.7 Recent Developments 
      20.4.8 SWOT Analysis 
 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/98746-global-tb-diagnostic-market-2015-2019